De Diego M, Laviada M D, Enjuanes L, Escribano J M
Departamento de Sanidad Animal-Instituto Nacional de Investigacíon y Tecnología Agraria y Alimentaria, Madrid, Spain.
J Virol. 1992 Nov;66(11):6502-8. doi: 10.1128/JVI.66.11.6502-6508.1992.
The epitope specificity of the protective immune response against swine transmissible gastroenteritis (TGE) has been investigated by using circulating and secretory antibodies. This study was carried out with sows vaccinated with TGEV or the antigenically related porcine respiratory coronavirus (PRCV). TGEV vaccination of sows resulted in greater lactogenic protection of suckling piglets against TGEV challenge and a higher secretory immune response than PRCV vaccination did. These differences in the immune response were conditioned by the route of antigen presentation as a result of the different tropism of each virus. Epitopes on S protein, and in particular those contained in its antigenic site. A, were more immunogenic than epitopes on N and M proteins in both groups of vaccinated sows, as determined by a competitive radioimmunoassay. Minor differences in antibody response against the previously defined antigenic subsites Aa, Ab, and Ac were also detected, with subsite Ab being the most antigenic in both TGEV- and PRCV-immune sows. These findings suggest that antigenic site A on S protein, involved in virus neutralization, is the immunodominant site in pregnant sows that confer lactogenic protection. They also validate, in experiments with secretory antibodies, the antigenic maps made with murine monoclonal antibodies. Therefore, this antigenic site should be considered for vaccine or diagnostic development.
通过使用循环抗体和分泌抗体,对猪传染性胃肠炎(TGE)保护性免疫反应的表位特异性进行了研究。本研究使用接种了TGEV或抗原相关的猪呼吸道冠状病毒(PRCV)的母猪开展。与接种PRCV相比,给母猪接种TGEV能为哺乳仔猪提供更强的抗TGEV攻击的泌乳保护作用,且分泌免疫反应更高。由于每种病毒的嗜性不同,抗原呈递途径决定了免疫反应的这些差异。通过竞争性放射免疫测定法确定,在两组接种疫苗的母猪中,S蛋白上的表位,尤其是其抗原位点A中的表位,比N蛋白和M蛋白上的表位更具免疫原性。还检测到针对先前定义的抗原亚位点Aa、Ab和Ac的抗体反应存在微小差异,亚位点Ab在TGEV免疫和PRCV免疫的母猪中都是最具抗原性的。这些发现表明,参与病毒中和的S蛋白上的抗原位点A是怀孕母猪中赋予泌乳保护作用的免疫显性位点。它们还在分泌抗体实验中验证了用鼠单克隆抗体制备的抗原图谱。因此,在疫苗或诊断试剂开发中应考虑这个抗原位点。